UK Markets close in 3 hrs 47 mins

Innate Pharma S.A. (IPHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.8100-0.3100 (-7.52%)
At close: 04:00PM EST
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) -0.05
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 311.9500
52-week low 33.0200
50-day moving average 34.7804
200-day moving average 34.5389

Share statistics

Avg vol (3-month) 375.05k
Avg vol (10-day) 345.06k
Shares outstanding 579.31M
Implied shares outstanding 6N/A
Float 851.17M
% held by insiders 10.00%
% held by institutions 11.19%
Shares short (14 Dec 2021) 430.65k
Short ratio (14 Dec 2021) 40.44
Short % of float (14 Dec 2021) 4N/A
Short % of shares outstanding (14 Dec 2021) 40.04%
Shares short (prior month 14 Nov 2021) 450.77k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin -156.64%
Operating margin (ttm)-72.13%

Management effectiveness

Return on assets (ttm)-7.43%
Return on equity (ttm)-45.33%

Income statement

Revenue (ttm)49.39M
Revenue per share (ttm)0.62
Quarterly revenue growth (yoy)-57.30%
Gross profit (ttm)11.84M
EBITDA -28.49M
Net income avi to common (ttm)-77.37M
Diluted EPS (ttm)-1.1070
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)119.32M
Total cash per share (mrq)1.51
Total debt (mrq)16.5M
Total debt/equity (mrq)12.35
Current ratio (mrq)3.04
Book value per share (mrq)1.69

Cash flow statement

Operating cash flow (ttm)-24.9M
Levered free cash flow (ttm)-47.08M